Research graph
References from Synergistic epigenetic modulation and ferroptosis induction via codelivery of Decitabine and Sorafenib for potent anti-tumor therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Bismuth-Based nanomaterials: recent advances in tumor targeting and synergistic cancer therapy techniques
10.1002/adhm.201901695 · 2020 · External reference
10.1016/j.redox.2024.103211
10.1016/j.redox.2024.103211 · External reference
10.1016/j.colsurfb.2021.111833
10.1016/j.colsurfb.2021.111833 · External reference
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
10.1186/s12943-021-01346-2 · 2021 · External reference
10.1038/s41571-020-00462-0
10.1038/s41571-020-00462-0 · External reference
Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
10.1016/j.phrs.2024.107328 · 2024 · External reference
The application of histone deacetylases inhibitors in glioblastoma
10.1186/s13046-020-01643-6 · 2020 · External reference
10.1038/sj.onc.1205699
10.1038/sj.onc.1205699 · External reference
Ferroptosis and the tumor microenvironment
2024 · External reference
10.1021/acsnano.4c01253
10.1021/acsnano.4c01253 · External reference
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
2022 · External reference
10.1016/j.jconrel.2015.03.033
10.1016/j.jconrel.2015.03.033 · External reference
10.1172/jci99032
10.1172/jci99032 · External reference
10.1016/j.addr.2015.10.023
10.1016/j.addr.2015.10.023 · External reference
10.1080/2162402x.2016.1164919
10.1080/2162402x.2016.1164919 · External reference
10.1021/acsnano.3c03352
10.1021/acsnano.3c03352 · External reference
DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma
2024 · External reference
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma
10.1126/scitranslmed.aao4680 · 2018 · External reference
Exosome-based theranostic for gastrointestinal cancer: advances in biomarker discovery and therapeutic engineering
10.1002/smtd.202402058 · 2025 · External reference
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
2019 · External reference
Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors
10.1016/j.canlet.2014.08.010 · 2014 · External reference
10.1016/j.bioactmat.2020.08.023
10.1016/j.bioactmat.2020.08.023 · External reference
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
10.1038/s43018-021-00249-x · 2021 · External reference
10.1158/2159-8290.cd-12-0076
10.1158/2159-8290.cd-12-0076 · External reference
10.7150/thno.39434
10.7150/thno.39434 · External reference
10.1038/s41573-018-0006-z
10.1038/s41573-018-0006-z · External reference
Advances
2020 · External reference
10.1007/s13238-021-00846-7
10.1007/s13238-021-00846-7 · External reference
10.1021/jacs.3c13165
10.1021/jacs.3c13165 · External reference
A mitochondria-targeted biomimetic nanomedicine capable of reversing drug resistance in colorectal cancer through mitochondrial dysfunction
10.1002/advs.202410630 · 2025 · External reference
Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021
2024 · External reference
10.1016/j.redox.2022.102564
10.1016/j.redox.2022.102564 · External reference
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
2023 · External reference
Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
10.1186/s12951-024-02298-7 · 2024 · External reference
10.1016/j.bbcan.2019.04.004
10.1016/j.bbcan.2019.04.004 · External reference
10.3390/pharmaceutics12070680
10.3390/pharmaceutics12070680 · External reference
A multifunctional Fe-EGCG@RSL3 nanomedicine synergizes ferroptosis induction and tumor microenvironment remodeling for enhanced bladder cancer immunotherapy
2025 · External reference
10.1158/0008-5472.can-23-2796
10.1158/0008-5472.can-23-2796 · External reference
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
10.1186/s12951-022-01472-z · 2022 · External reference
Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia
10.1016/j.jconrel.2022.12.026 · 2023 · External reference
Epigenetic reprogramming holds promise in enhancing anti-tumor efficacy of CAR T cell therapy
10.1016/j.biotechadv.2025.108649 · 2025 · External reference
Ultrasmall metal TPZ complexes with deep tumor penetration for enhancing radiofrequency ablation therapy and inducing antitumor immune responses
2024 · External reference
